齊藤 真弘

Medicine and Dentistry

1. Patient 100%
2. Reflux 46%
3. Barrett Esophagus 37%
4. Symptom 37%
5. Adenocarcinoma 35%
6. Esophageal Squamous Cell Carcinoma 34%
7. Neoplasm 31%
8. Predictor 31%
9. Vonoprazan 29%
10. Lesion 26%
11. Proton-Pump Inhibitor 25%
12. Endoscopic Submucosal Dissection 24%
13. Gastroesophageal Reflux 24%
14. Therapeutic Procedure 21%
15. Amyloidosis 21%
16. Mortality 19%
17. Follow up 19%
18. Development 18%
19. Esophageal Adenocarcinoma 17%
20. Mucosa 16%
21. Hazard Ratio 16%
22. Odds Ratio 16%
23. Morphology 15%
24. Acid 15%
25. Bleeding 14%
26. Inpatient 14%
27. Stomach Cancer 14%
28. Prevalence 13%
29. Association 13%
30. Biopsy 13%
31. Metastatic Carcinoma 13%
32. Narrow Band Imaging 13%
33. Endoscopic Hemostasis 12%
34. Hospital 12%
35. Surveillance 12%
36. Stomach 10%
37. Amyloid 10%
38. Eructation 10%
39. Stomach Adenocarcinoma 10%
40. Steroid 10%
41. Nitric Oxide 10%
42. Squamous Cell Carcinoma 10%
43. Haemophilia A 10%
44. Magnifying Endoscopy 9%
45. Suction 9%
46. Endoscopy 9%
47. Examination 9%
48. Non Erosive Reflux Disease 9%
49. Fibroblast 8%
50. Stomach Carcinoma 8%